IP Library Granted Patent US 9,671,348
Granted Patent B2
US 9,671,348 · App. 13/991,652 · Granted Jun 6, 2017

Method for measuring component by treating aqueous sample with alpha-keto acid and then converting component to hydrogen peroxide

Inventor: Tomomi Murakami (Shizuoka, JP)
Assignee: KYOWA MEDEX CO., LTD.
G01N21/77C09B21/00C12Q1/28G01N21/78G01N2333/908
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,671,348
App. No.
13/991,652
Granted
Jun 6, 2017
Kind
B2
Abstract

The present invention provides a method for measuring a component to be measured in a sample, comprising converting the component to be measured in the sample into hydrogen peroxide and measuring the formed hydrogen peroxide in the presence of an α-keto acid using an oxidative-coloring chromogen. The present invention also provides a method for suppressing the influence of a peroxide on a method of converting a component to be measured in a sample into hydrogen peroxide and measuring the formed hydrogen peroxide using an oxidative-coloring chromogen, the suppression method comprising using an α-keto acid. The measuring method and the suppression method of the present invention using an α-keto acid suppress the influence of a peroxide to give an accurate measurement of the component to be measured in the sample.

Claims (11)

1. A method for suppressing the influence of a peroxide on a method for measuring hemoglobin A1c in a sample containing peroxides comprising the steps of:

adding an α-keto acid to an aqueous solution containing the sample to react with the peroxides contained therein;

converting hemoglobin A1c into hydrogen peroxide in the aqueous solution; and

reacting the formed hydrogen peroxide with an oxidative-coloring chromogen in the presence of the α-keto acid, whereby

influence of the peroxides other than said formed hydrogen peroxide on said reaction of said hydrogen peroxide with said oxidative-coloring chromogen is suppressed.

2. The method according to claim 1 , wherein the α-keto acid is an α-keto acid selected from the group consisting of pyruvic acid, α-ketoglutaric acid, and oxaloacetic acid.

3. The method according to claim 1 , wherein the oxidative-coloring chromogen is a leuco chromogen.

4. The method according to claim 3 , wherein the leuco chromogen is a phenothiazine derivative.

5. The method according to claim 4 , wherein the phenothiazine derivative is 10-(carboxymethylaminocarbonyl)-3,7-bis(dimethylamino)phenothiazine.

6. The method according to claim 1 , wherein the oxidative-coloring chromogen is an oxidative coupling-type chromogen.

7. The method according to claim 6 , wherein the oxidation coupling-type chromogen is a combination of a coupler and an aniline derivative or a phenol derivative.

Assignments (4)
CHANGE OF NAME Recorded Sep 23, 2025
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 072925/0508 →
CHANGE OF NAME Recorded Sep 23, 2025
From: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 072925/0657 →
CHANGE OF NAME Recorded Sep 23, 2025
From: MINARIS MEDICAL CO., LTD.
To: CANON MEDICAL DIAGNOSTICS CORPORATION
Reel/Frame 072925/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2013
From: MURAKAMI, TOMOMI
To: KYOWA MEDEX CO., LTD.
Reel/Frame 030548/0450 →
Priority Claims (1)
JP 2010-276550 · Dec 13, 2010 · national
Continuity (1)
Related Publication 20130288283A1 · Oct 31, 2013